Literature DB >> 20593247

Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.

Alan K H Tam1, Don Ilodigwe, Jay Mocco, Stephan Mayer, Neal Kassell, Daniel Ruefenacht, Peter Schmiedek, Stephan Weidauer, Alberto Pasqualin, R Loch Macdonald.   

Abstract

BACKGROUND: Systemic inflammatory response syndrome (SIRS) may develop after aneurysmal subarachnoid hemorrhage (SAH). We investigated factors associated with SIRS after SAH, whether SIRS was associated with complications of SAH such as vasospasm, cerebral infarction, and clinical outcome, and whether SIRS could contribute to a difference in outcome between patients treated by endovascular coiling or neurosurgical clipping of the ruptured aneurysm.
METHODS: This was exploratory analysis of 413 patients in the CONSCIOUS-1 study. SIRS was diagnosed if the patient had at least 2 of 4 variables (hypothermia/fever, tachycardia, tachypnea, and leukocytosis/leukopenia) within 4 days of admission. Clinical outcome was measured on the Glasgow outcome scale 3 months after SAH. The relationship between clinical and radiologic variables and SIRS, angiographic vasospasm, delayed ischemic neurologic deficit (DIND), cerebral infarction, vasospasm-related infarction, and clinical outcome were modeled with uni- and multivariable analyses.
RESULTS: 63% of patients developed SIRS. Many factors were associated with SIRS in univariate analysis, but only poor WFNS grade and pneumonia were independently associated with SIRS in multivariable analysis. SIRS burden (number of SIRS variables per day over the first 4 days) was associated with poor outcome, but not with angiographic vasospasm, DIND, or cerebral infarction. The method of aneurysm treatment was not associated with SIRS.
CONCLUSION: SIRS was associated with poor outcome but not angiographic vasospasm, DIND, or cerebral infarction after SAH in the CONSCIOUS-1 data. There was no support for the notion that neurosurgical clipping is associated with a greater risk of SIRS than endovascular coiling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593247     DOI: 10.1007/s12028-010-9402-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  38 in total

Review 1.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

2.  Thromboembolism and delayed cerebral ischemia after subarachnoid hemorrhage: an autopsy study.

Authors:  Sherman C Stein; Kevin D Browne; Xiao-Han Chen; Douglas H Smith; David I Graham
Journal:  Neurosurgery       Date:  2006-10       Impact factor: 4.654

3.  The blood leucocyte count and its prognostic significance in subarachnoid haemorrhage.

Authors:  G Neil-Dwyer; J Cruickshank
Journal:  Brain       Date:  1974-03       Impact factor: 13.501

4.  Fever burden and functional recovery after subarachnoid hemorrhage.

Authors:  Andrew M Naidech; Bernard R Bendok; Richard A Bernstein; Mark J Alberts; H Hunt Batjer; Charles M Watts; Thomas P Bleck
Journal:  Neurosurgery       Date:  2008-08       Impact factor: 4.654

5.  Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis.

Authors:  I A C van der Bilt; D Hasan; W P Vandertop; A A M Wilde; A Algra; F C Visser; G J E Rinkel
Journal:  Neurology       Date:  2009-02-17       Impact factor: 9.910

6.  Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in Europe, Australia, and New Zealand.

Authors:  N F Kassell; E C Haley; C Apperson-Hansen; W M Alves
Journal:  J Neurosurg       Date:  1996-02       Impact factor: 5.115

7.  The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage.

Authors:  Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Impact of nosocomial infectious complications after subarachnoid hemorrhage.

Authors:  Jennifer A Frontera; Andres Fernandez; J Michael Schmidt; Jan Claassen; Katja E Wartenberg; Neeraj Badjatia; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Neurosurgery       Date:  2008-01       Impact factor: 4.654

9.  Impact of medical complications on outcome after subarachnoid hemorrhage.

Authors:  Katja E Wartenberg; J Michael Schmidt; Jan Claassen; Richard E Temes; Jennifer A Frontera; Noeleen Ostapkovich; Augusto Parra; E Sander Connolly; Stephan A Mayer
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

10.  International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion.

Authors:  Andrew J Molyneux; Richard S C Kerr; Ly-Mee Yu; Mike Clarke; Mary Sneade; Julia A Yarnold; Peter Sandercock
Journal:  Lancet       Date:  2005 Sep 3-9       Impact factor: 79.321

View more
  31 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

2.  The occurrence of pneumonia diagnosis among neurosurgical patients: the definition matters.

Authors:  Petri Kuusinen; Tero Ala-Kokko; Airi Jartti; Lauri Ahvenjarvi; Pirjo Saynajakangas; Pasi Ohtonen; Hannu Syrjala
Journal:  Neurocrit Care       Date:  2012-02       Impact factor: 3.210

3.  The Association Between Spontaneous Hyperventilation, Delayed Cerebral Ischemia, and Poor Neurological Outcome in Patients with Subarachnoid Hemorrhage.

Authors:  Craig A Williamson; Kyle M Sheehan; Renuka Tipirneni; Christopher D Roark; Aditya S Pandey; B Gregory Thompson; Venkatakrishna Rajajee
Journal:  Neurocrit Care       Date:  2015-12       Impact factor: 3.210

4.  Systemic Inflammatory Response Syndrome and Outcomes in Intracerebral Hemorrhage.

Authors:  Amelia K Boehme; Angela N Hays; Kimberly P Kicielinski; Kanika Arora; Niren Kapoor; Michael J Lyerly; Alissa Gadpaille; Harn Shiue; Karen Albright; David Miller; Mitchell S V Elkind; Mark R Harrigan
Journal:  Neurocrit Care       Date:  2016-08       Impact factor: 3.210

Review 5.  Current management of delayed cerebral ischemia: update from results of recent clinical trials.

Authors:  Shakira Brathwaite; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2013-12-13       Impact factor: 6.829

6.  Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage.

Authors:  Patrick Schuss; Alexis Hadjiathanasiou; Simon Brandecker; Ági Güresir; Hartmut Vatter; Erdem Güresir
Journal:  J Neurol       Date:  2018-10-13       Impact factor: 4.849

7.  Time from onset of SIRS to antibiotic administration and outcomes after subarachnoid hemorrhage.

Authors:  Elan L Guterman; Hooman Kamel; Carmil Azran; Maulik P Shah; J Claude Hemphill; Wade S Smith; Babak B Navi
Journal:  Neurocrit Care       Date:  2014-08       Impact factor: 3.210

Review 8.  Spontaneous subarachnoid hemorrhage and glucose management.

Authors:  Erich Schmutzhard; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 9.  Delayed neurological deterioration after subarachnoid haemorrhage.

Authors:  R Loch Macdonald
Journal:  Nat Rev Neurol       Date:  2013-12-10       Impact factor: 42.937

10.  Electronic Health Data Predict Outcomes After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Sahar F Zafar; Eva N Postma; Siddharth Biswal; Lucas Fleuren; Emily J Boyle; Sophia Bechek; Kathryn O'Connor; Apeksha Shenoy; Durga Jonnalagadda; Jennifer Kim; Mouhsin S Shafi; Aman B Patel; Eric S Rosenthal; M Brandon Westover
Journal:  Neurocrit Care       Date:  2018-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.